DE602007011384D1 - Verfahren zur herstellung lipophiler pharmazeutisch akzeptabler salze aus pemetrexed-disäure - Google Patents
Verfahren zur herstellung lipophiler pharmazeutisch akzeptabler salze aus pemetrexed-disäureInfo
- Publication number
- DE602007011384D1 DE602007011384D1 DE602007011384T DE602007011384T DE602007011384D1 DE 602007011384 D1 DE602007011384 D1 DE 602007011384D1 DE 602007011384 T DE602007011384 T DE 602007011384T DE 602007011384 T DE602007011384 T DE 602007011384T DE 602007011384 D1 DE602007011384 D1 DE 602007011384D1
- Authority
- DE
- Germany
- Prior art keywords
- pemetrexed
- acceptable salts
- lactic acid
- pharmaceutical acceptable
- lipophilic pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000003839 salts Chemical class 0.000 title abstract 3
- 239000004310 lactic acid Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- QOFFJEBXNKRSPX-ZDUSSCGKSA-N pemetrexed Chemical class C1=N[C]2NC(N)=NC(=O)C2=C1CCC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 QOFFJEBXNKRSPX-ZDUSSCGKSA-N 0.000 abstract 3
- 229960005079 pemetrexed Drugs 0.000 abstract 2
- NYDXNILOWQXUOF-UHFFFAOYSA-L disodium;2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioate Chemical class [Na+].[Na+].C=1NC=2NC(N)=NC(=O)C=2C=1CCC1=CC=C(C(=O)NC(CCC([O-])=O)C([O-])=O)C=C1 NYDXNILOWQXUOF-UHFFFAOYSA-L 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (16)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83730306P | 2006-08-14 | 2006-08-14 | |
| US83763706P | 2006-08-15 | 2006-08-15 | |
| US83955106P | 2006-08-22 | 2006-08-22 | |
| US84503106P | 2006-09-14 | 2006-09-14 | |
| US84729106P | 2006-09-25 | 2006-09-25 | |
| US85513906P | 2006-10-30 | 2006-10-30 | |
| US86055706P | 2006-11-21 | 2006-11-21 | |
| US86055406P | 2006-11-21 | 2006-11-21 | |
| US88017807P | 2007-01-11 | 2007-01-11 | |
| US88017907P | 2007-01-11 | 2007-01-11 | |
| US89992807P | 2007-02-06 | 2007-02-06 | |
| US93655307P | 2007-06-20 | 2007-06-20 | |
| US95832607P | 2007-07-02 | 2007-07-02 | |
| US95821307P | 2007-07-03 | 2007-07-03 | |
| US95841307P | 2007-07-05 | 2007-07-05 | |
| PCT/US2007/018098 WO2008021411A2 (en) | 2006-08-14 | 2007-08-14 | Processes for the preparation of lyophilized pharmaceutically acceptable salts of pemetrexed diacid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602007011384D1 true DE602007011384D1 (de) | 2011-02-03 |
Family
ID=49584971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602007011384T Active DE602007011384D1 (de) | 2006-08-14 | 2007-08-14 | Verfahren zur herstellung lipophiler pharmazeutisch akzeptabler salze aus pemetrexed-disäure |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8629152B2 (de) |
| EP (1) | EP1943252B1 (de) |
| JP (1) | JP2008543976A (de) |
| KR (1) | KR101083230B1 (de) |
| AT (1) | ATE492547T1 (de) |
| DE (1) | DE602007011384D1 (de) |
| ES (1) | ES2356792T3 (de) |
| TW (1) | TWI377955B (de) |
| WO (1) | WO2008021411A2 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101687872A (zh) | 2007-04-03 | 2010-03-31 | 雷迪博士实验室有限公司 | 培美曲塞的固体形式 |
| CN101684121B (zh) * | 2008-09-22 | 2013-04-03 | 重庆医药工业研究院有限责任公司 | 培美曲塞二酸的新晶型及其制备方法 |
| CN102838602B (zh) * | 2011-06-21 | 2016-08-03 | 重庆医药工业研究院有限责任公司 | 培美曲塞氧化物及其制备方法 |
| LT2854768T (lt) | 2012-05-30 | 2017-06-12 | Fresenius Kabi Oncology Limited | Pemetreksedo farmacinės kompozicijos |
| US20150259348A1 (en) * | 2012-10-17 | 2015-09-17 | Shilpa Medicare Limited | Process for preparing pemetrexed di potassium and its hydrates |
| KR101260636B1 (ko) * | 2012-11-29 | 2013-05-13 | 씨제이제일제당 (주) | 안정화된 페메트렉시드 제제 |
| ZA201400898B (en) | 2013-02-06 | 2015-12-23 | Cipla Ltd | Pemetrexed complexes and pharmaceutical compositions containing pemetrexed complexes |
| WO2014185797A1 (en) | 2013-05-17 | 2014-11-20 | Instytut Farmaceutyczny | Process for the preparation of high purity amorphous pemetrexed disodium and crystalline forms of n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3- d] pyrimidin-5-yl)ethyl] benzoyl]-l-glutamic acid |
| WO2014198338A1 (en) * | 2013-06-14 | 2014-12-18 | Synthon B.V. | Stable pemetrexed arginine salt and compositions comprising it |
| KR101703980B1 (ko) | 2013-12-30 | 2017-02-08 | 주식회사 삼양바이오팜 | 항산화제를 함유하지 않는 약학 조성물 및 그의 제조방법 |
| NZ630299A (en) * | 2014-06-30 | 2014-11-28 | Shilpa Medicare Ltd | Pemetrexed dipotassium formulations |
| US20170239250A1 (en) | 2016-02-19 | 2017-08-24 | Eagle Pharmaceuticals, Inc. | Pemetrexed formulations |
| AU2016393213B2 (en) * | 2016-02-19 | 2022-03-31 | Eagle Pharmaceuticals, Inc. | Pemetrexed formulations |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL96531A (en) | 1989-12-11 | 1995-08-31 | Univ Princeton | History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them) |
| KR0162654B1 (ko) | 1989-12-11 | 1998-11-16 | 알렌 제이. 시니스갤리 | N-(피롤로[2,3-d]피리미딘-3-일아크릴)-글루타민산 유도체 |
| CA2032695A1 (en) | 1989-12-20 | 1991-06-21 | Hiroshi Akimoto | Condensed heterocyclic compounds, their production and use |
| US5416211A (en) | 1992-09-25 | 1995-05-16 | Eli Lilly And Company | Process for preparing 5-substituted pyrrolo-[2,3-d]pyrimidines |
| US6262262B1 (en) * | 1997-09-26 | 2001-07-17 | Eli Lilly And Company | Processes and intermediates useful to make antifolates |
| EP1212325A2 (de) | 1999-08-23 | 2002-06-12 | Eli Lilly And Company | Neue kristalline form von disodium n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3-d]-pyrimidin-5-yl)ethyl]benzoyl]-l-glutamic säuresalz und verfahren hierfür |
| KR100744917B1 (ko) | 2000-02-25 | 2007-08-01 | 일라이 릴리 앤드 캄파니 | 신규한 결정형의Ｎ-[4-[2-(2-아미노-4,7-디히드로-4-옥소-3Ｈ-피롤로[2,3-ｄ]피리미딘-5-일)에틸]벤조일]-Ｌ-글루탐산 및 이의 제조방법 |
| JP2008530216A (ja) * | 2005-02-16 | 2008-08-07 | シェーリング コーポレイション | Ｃｘｃｒ３アンタゴニスト活性を有する、複素環で置換された新規のピリジンまたはフェニル化合物 |
| US8158152B2 (en) * | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| CN101687872A (zh) | 2007-04-03 | 2010-03-31 | 雷迪博士实验室有限公司 | 培美曲塞的固体形式 |
-
2007
- 2007-08-14 JP JP2008530049A patent/JP2008543976A/ja active Pending
- 2007-08-14 US US11/893,234 patent/US8629152B2/en active Active
- 2007-08-14 KR KR1020087029220A patent/KR101083230B1/ko active Active
- 2007-08-14 AT AT07836879T patent/ATE492547T1/de not_active IP Right Cessation
- 2007-08-14 ES ES07836879T patent/ES2356792T3/es active Active
- 2007-08-14 DE DE602007011384T patent/DE602007011384D1/de active Active
- 2007-08-14 WO PCT/US2007/018098 patent/WO2008021411A2/en not_active Ceased
- 2007-08-14 EP EP07836879A patent/EP1943252B1/de active Active
- 2007-08-14 TW TW096130058A patent/TWI377955B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| TWI377955B (en) | 2012-12-01 |
| ES2356792T3 (es) | 2011-04-13 |
| WO2008021411A3 (en) | 2008-04-10 |
| WO2008021411A2 (en) | 2008-02-21 |
| TW200824720A (en) | 2008-06-16 |
| EP1943252B1 (de) | 2010-12-22 |
| EP1943252A2 (de) | 2008-07-16 |
| KR101083230B1 (ko) | 2011-11-11 |
| US8629152B2 (en) | 2014-01-14 |
| JP2008543976A (ja) | 2008-12-04 |
| ATE492547T1 (de) | 2011-01-15 |
| US20080139810A1 (en) | 2008-06-12 |
| KR20090035478A (ko) | 2009-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602007011384D1 (de) | Verfahren zur herstellung lipophiler pharmazeutisch akzeptabler salze aus pemetrexed-disäure | |
| EP2297079A4 (de) | Verfahren zur herstellung von glycolsäure | |
| DE602007011843D1 (de) | Verfahren zur Herstellung von Gruppe-III-Nitridkristallen | |
| AU2016219654A1 (en) | Crystallization method and bioavailability | |
| DE602007007146D1 (de) | Verfahren zur Herstellung von Müsliriegeln mit verbesserter Konsistenz | |
| DE602005000765D1 (de) | Verfahren zur Herstellung von Ivabradine und deren pharmazeutisch verträgliche Säureadditionssalze | |
| EP1934354A4 (de) | Verfahren zur herstellung von hybridsaat | |
| DE602008000298D1 (de) | Verfahren zur Herstellung von Polyesternanokompositen | |
| CY1110812T1 (el) | Παραγωγα διφαινυλοξυοξικου οξεος για τη θεραπεια αναπνευστικων διαταραχων | |
| DE502007003700D1 (de) | Verfahren zur Herstellung von Glycerin | |
| DE102009035301A8 (de) | Verfahren zur Herstellung von Dibenz[c,e][1,2]-oxaphosphorin-Derivaten, Amino-dibenz[c,e][1,2]-oxaphosphorin sowie deren Verwendung | |
| ATE546436T1 (de) | Verfahren zur herstellung von 2-amino-5- cyanobenzoesäurederivaten | |
| EP2302066A4 (de) | Verfahren zur herstellung von aminohydroxybenzoesäure | |
| CL2007003754A1 (es) | Compuestos derivados de aril(heteroaril)alquil-amina; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; combinacion farmaceutica; y uso en el tratamiento de enfermedades tales como bronquitis, enfisema pulmonar y epoc. | |
| DE502006001136D1 (de) | Verfahren zur herstellung von entschäumerformulierungen | |
| DE602005007734D1 (de) | Verfahren zur herstellung von telmisartan | |
| ATE517093T1 (de) | Verfahren zur herstellung von ivabradine und deren pharmazeutisch verträglichen säureadditionssalzen | |
| DE602006010302D1 (de) | Verfahren zur Herstellung von 5-methyl-2-furfural | |
| ATE523494T1 (de) | Verfahren zur herstellung von ivabradin und dessen pharmazeutisch verträglichen säureadditionssalzen | |
| DE602006009562D1 (de) | Verfahren zur herstellung von ferrisuccinylcasein | |
| EP1914220A4 (de) | Verfahren zur herstellung von 2-hydroxyestern | |
| DE602005024566D1 (de) | Verfahren zur herstellung von 2-amino-5-iodobenzoesäure | |
| EA201101638A1 (ru) | Новые твердые формы {[(2s,5r,8s,11s)-5-бензил-11-(3-гуанидинопропил)-8-изопропил-7-метил-3,6,9,12,15-пентаоксо-1,4,7,10,13-пентаазациклопентадец-2-ил]уксусной кислоты} и способы их получения | |
| EP2243769A4 (de) | Verfahren zur herstellung von optisch aktivem fluoramin | |
| DE602006018182D1 (de) | Verfahren zur herstellung von aralkyloxypyrrolidinderivaten |